Male CNS – Cell Type Explorer


Post
Pre

LA
-
-

ME 1	ME 2	ME 3	ME 4	ME 5	ME 6	ME 7	ME 8	ME 9	ME 10	Total
-	-	-	-	-	200	403	-	-	-	603
-	-	-	-	-	6	22	-	-	-	28


Post
Pre

LO 1	LO 2	LO 3	LO 4	LO 5A	LO 5B	LO 6	Total
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-

AME
32
-


Post
Pre

LOP 1	LOP 2	LOP 3	LOP 4	Total
-	-	-	-	-
-	-	-	-	-

central brain
126
256

Neuron Visualization ⧉

Dark Light

ROI Name	∑ In	% In	log ratio	∑ Out	% Out
ME(R)	603	77.9%	-4.43	28	9.9%
PLP(R)	86	11.1%	0.78	148	52.1%
CentralBrain-unspecified	31	4.0%	0.51	44	15.5%
SLP(R)	9	1.2%	2.83	64	22.5%
AME(R)	32	4.1%	-inf	0	0.0%
Optic-unspecified(R)	13	1.7%	-inf	0	0.0%

upstream partner	#	NT	conns MeVP39	% In	CV
MeTu2a (R)	36	ACh	234	30.9%	0.5
MeTu3a (R)	17	ACh	108	14.3%	0.5
MeVPMe10 (L)	2	Glu	84	11.1%	0.0
Cm4 (R)	29	Glu	64	8.5%	0.7
MeTu3b (R)	18	ACh	31	4.1%	0.5
MeVPaMe2 (L)	1	Glu	26	3.4%	0.0
MeVPLo2 (L)	6	ACh	26	3.4%	0.5
CB2377 (R)	2	ACh	22	2.9%	0.3
aMe22 (R)	1	Glu	20	2.6%	0.0
MeVP15 (R)	10	ACh	19	2.5%	0.5
Dm-DRA1 (R)	8	Glu	16	2.1%	0.5
MeVPLo2 (R)	5	ACh	15	2.0%	0.6
Cm14 (R)	8	GABA	14	1.8%	0.6
MeTu2b (R)	6	ACh	8	1.1%	0.4
aMe13 (L)	1	ACh	6	0.8%	0.0
aMe4 (R)	2	ACh	4	0.5%	0.5
Cm21 (R)	3	GABA	4	0.5%	0.4
MeVP14 (R)	4	ACh	4	0.5%	0.0
Cm18 (R)	1	Glu	3	0.4%	0.0
Mi15 (R)	2	ACh	3	0.4%	0.3
MeTu3c (R)	2	ACh	3	0.4%	0.3
Cm-DRA (R)	2	ACh	3	0.4%	0.3
Cm28 (R)	2	Glu	3	0.4%	0.3
OA-AL2i4 (R)	1	OA	2	0.3%	0.0
Cm34 (R)	1	Glu	2	0.3%	0.0
Cm8 (R)	2	GABA	2	0.3%	0.0
CB2377 (L)	1	ACh	1	0.1%	0.0
MeVC27 (L)	1	unc	1	0.1%	0.0
Dm8b (R)	1	Glu	1	0.1%	0.0
Tm39 (R)	1	ACh	1	0.1%	0.0
CB1059 (R)	1	Glu	1	0.1%	0.0
Cm20 (R)	1	GABA	1	0.1%	0.0
SLP322 (R)	1	ACh	1	0.1%	0.0
Cm22 (R)	1	GABA	1	0.1%	0.0
SMP168 (R)	1	ACh	1	0.1%	0.0
HBeyelet (R)	1	HA	1	0.1%	0.0
SLP360_d (R)	1	ACh	1	0.1%	0.0
Cm24 (R)	1	Glu	1	0.1%	0.0
SLP249 (R)	1	Glu	1	0.1%	0.0
SLP368 (R)	1	ACh	1	0.1%	0.0
LHPV5i1 (R)	1	ACh	1	0.1%	0.0
aMe6a (R)	1	ACh	1	0.1%	0.0
DN1a (R)	1	Glu	1	0.1%	0.0
aMe3 (R)	1	Glu	1	0.1%	0.0
MeVPMe4 (L)	1	Glu	1	0.1%	0.0
MeVC20 (R)	1	Glu	1	0.1%	0.0
aMe12 (R)	1	ACh	1	0.1%	0.0
MeVPaMe1 (R)	1	ACh	1	0.1%	0.0
aMe12 (L)	1	ACh	1	0.1%	0.0
MeVC21 (R)	1	Glu	1	0.1%	0.0
MeVP29 (R)	1	ACh	1	0.1%	0.0
MeVPMe11 (L)	1	Glu	1	0.1%	0.0
MeVCMe1 (R)	1	ACh	1	0.1%	0.0
aMe17e (R)	1	Glu	1	0.1%	0.0
DNpe053 (L)	1	ACh	1	0.1%	0.0
WED092 (L)	1	ACh	1	0.1%	0.0
CT1 (L)	1	GABA	1	0.1%	0.0

downstream partner	#	NT	conns MeVP39	% Out	CV
FB8B (R)	2	Glu	192	30.0%	0.0
AVLP594 (R)	1	unc	54	8.5%	0.0
MeVP15 (R)	9	ACh	47	7.4%	0.7
SLP364 (R)	2	Glu	43	6.7%	0.3
aMe13 (L)	1	ACh	34	5.3%	0.0
CL356 (R)	2	ACh	34	5.3%	0.1
Cm14 (R)	8	GABA	22	3.4%	0.5
AVLP594 (L)	1	unc	21	3.3%	0.0
aMe22 (R)	1	Glu	19	3.0%	0.0
SMP529 (R)	1	ACh	17	2.7%	0.0
aMe13 (R)	1	ACh	15	2.3%	0.0
SLP368 (R)	1	ACh	13	2.0%	0.0
SMP217 (R)	2	Glu	12	1.9%	0.5
SMP229 (R)	4	Glu	10	1.6%	0.8
MeVC21 (R)	2	Glu	8	1.3%	0.8
AOTU056 (R)	2	GABA	8	1.3%	0.5
SLP266 (R)	1	Glu	6	0.9%	0.0
MeVP14 (R)	3	ACh	6	0.9%	0.4
SLP064 (R)	1	Glu	5	0.8%	0.0
DNp25 (R)	1	GABA	5	0.8%	0.0
DNg30 (R)	1	5-HT	5	0.8%	0.0
MeTu2b (R)	3	ACh	5	0.8%	0.3
Lat2 (R)	1	unc	4	0.6%	0.0
MeVC20 (R)	2	Glu	4	0.6%	0.0
MeTu3c (R)	4	ACh	4	0.6%	0.0
MeTu3a (R)	4	ACh	4	0.6%	0.0
SMP228 (R)	1	Glu	3	0.5%	0.0
SMP219 (R)	1	Glu	3	0.5%	0.0
aMe4 (R)	2	ACh	3	0.5%	0.3
SMP527 (R)	1	ACh	2	0.3%	0.0
CB1984 (R)	1	Glu	2	0.3%	0.0
CB1791 (R)	1	Glu	2	0.3%	0.0
SLP322 (R)	1	ACh	2	0.3%	0.0
CB0386 (R)	1	Glu	2	0.3%	0.0
CB2648 (R)	1	Glu	2	0.3%	0.0
aMe8 (R)	1	unc	2	0.3%	0.0
aMe30 (R)	1	Glu	2	0.3%	0.0
MeTu3b (R)	2	ACh	2	0.3%	0.0
Cm18 (R)	1	Glu	1	0.2%	0.0
MeTu2a (R)	1	ACh	1	0.2%	0.0
SMP226 (R)	1	Glu	1	0.2%	0.0
SMP223 (R)	1	Glu	1	0.2%	0.0
Cm20 (R)	1	GABA	1	0.2%	0.0
Cm21 (R)	1	GABA	1	0.2%	0.0
CB3173 (R)	1	ACh	1	0.2%	0.0
Cm27 (R)	1	Glu	1	0.2%	0.0
Cm-DRA (R)	1	ACh	1	0.2%	0.0
Cm24 (R)	1	Glu	1	0.2%	0.0
SLP249 (R)	1	Glu	1	0.2%	0.0
SMP183 (R)	1	ACh	1	0.2%	0.0
LoVP96 (R)	1	Glu	1	0.2%	0.0
MeVPaMe2 (R)	1	Glu	1	0.2%	0.0
DNp27 (R)	1	ACh	1	0.2%	0.0